Among patients with breast and prostate cancers, fatigue experienced during radiation therapy may be linked to activation of the proinflammatory cytokine network and its associated biomarkers. Medscape Medical News
Fear of losing hospital revenues from hospitalizations due to chemotherapy toxicity translates into pressure to give patients with poor prognoses less-than-optimal chemotherapy. Medscape Medical News
Investigations into the microenvironment of tumor cells suggest that aspects of inflammation promote tumor growth. But Dr. David Kerr finds a gap in our understanding of good and bad inflammation. Medscape Hematology-Oncology
The American Society of Clinical Oncology continues to recommend against the use of chemotherapy sensitivity and resistance assays, except in the setting of a clinical trial. br / iMedscape Medical News/i
